AI-Based sTIL analysis expands identification of HER2+ BC patients benefiting from pertuzumab

Empowering cancer care in Africa

Do all hormone sensitive prostate cancers need triplet therapy?

ESMO 2025: Highlights and analysis

ctDNA-guided adjuvant atezolizumab improves OS in MIBC

ctDNA-guided adjuvant chemo de-escalation reduces toxicity with comparable outcomes in stage III colon cancer

177Lu-PSMA-617 with androgen deprivation therapy plus ARPI improves PFS for mHSPC

MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection

Circulating tumour DNA a useful marker in CRC treatment efficacy, but only alongside others

Enhancing breast cancer care through AI and collaboration

ctDNA testing improves detection of treatable metastases compared to standard care in colorectal cancer

Tumour microenvironment and circulating biomarkers predict response to immunotherapy in advanced RCC